Tovorafenib FDA Approved for Treatment of Low-grade Gliomas in Children

 Great news! A new childhood cancer treatment has been approved by the FDA! From the pharmeceutical company's website:

"Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved OJEMDA (tovorafenib), a type II RAF inhibitor, for the treatment of patients 6 months of age and older with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. This indication is approved under accelerated approval based on response rate and duration of response. With the approval, Day One received a rare pediatric disease priority review voucher from the FDA."

 This treatment is specifically for low-grade gliomas (the most common brain cancer in children, affecting 1100 children per year) with the BRAF mutation, present in 75% of childhood low-grade gliomas. This treatment aims to stabilize or shrink the tumor and preserve quality of life for these children.

Congratulations to Day One and I hope that this truly improves the lives of many children. We need treatments made specifically for children, and this is a great step forward.

Comments

Post a Comment

Popular posts from this blog

Viral Therapy

    Viral therapy is a novel approach to treating cancers.  Infectious shells (viruses) are altered so that instead of causing illness, they fight it from the inside. Because of it's broad applicability, viral therapy shows promise in treating cancer. Read more about viral therapy: Columbus Ohio PubMed review of viral therapy Nationwide Hospital      There are many more articles on Pubmed that discuss various uses of viral therapy and oncolytic viruses. The abstracts are almost always free, and many articles are available through resources at local schools and public libraries.  Happy reading!
Read more

Common Types of Childhood Cancer

 I'm going to do some posts that give readers a background on childhood cancer throughout the year. My goal is to do at least a few related posts every month, for sure the awareness days and months, and then some other information, news, etc.  First, let's dive in to what types of cancers occur in children. There are many types of childhood cancer, hundreds in fact, especially when you consider subtypes. But which are the most common? In order of most to least common, by percent of childhood cancers, they are: Leukemias - 31% Brain and spinal tumors - 26% Lymphomas - 10% Soft tissue sarcomas - 7% Neuroblastoma - 6% Kidney tumors - 5% Bone tumors - 4% Germ cell tumors - 3% Retinoblastoma - 3% Liver tumors - 2% Other cancers - 4% According to the Children's Cancer and Leukemia Society from the UK via MacMillan Cancer Support ( x ). All childhood cancer is considered rare, with only a few hundred per million diagnosed annually. But if you add that up over the span of a childho
Read more

Vision Board

Image
 My county library is probably one of the most awesome library systems (I am super biased though) and actually is one of the busiest systems in the country. I love the system dearly. I love going to their events and often bring along a friend. For the first week of the year, I brought her to our newest library building for a Vision Boards workshop. I didn't think we would spend the whole hour and a half, but sure enough, we didn't roll out until just before the end of the workshop. I spent a lot of time combing through the magazines, picking just the perfect images and text for my board. I focused on my hobbies, especially cooking, things I want to do this year. I unfortunately didn't include a lot of art items, just based on what the magazines had, but also got a lot of cool foodie stuff and them some other pretty things.  Overall, I don't have one concrete vision for 2024. I have some resolutions, sure, and I have my goals. But I'm trying not to set the bar too hi
Read more